CTRI/2017/12/010864已完成3 期
Efficacy of Aprepitant and Olanzapine combination in the prevention of chemotherapy induced nausea and vomiting in carcinoma breast patients
Mysore medical college ad research institute0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Female patient with histopathologically
- •confirmed breast cancer
- •2. Chemotherapy naïve
- •3. No nausea/ vomiting in the past 24 hours were
排除标准
- •1. Patients with seizure disorder.
- •2. Brain metastasis.
- •3. Prior use of antipsychotic agents were excluded
研究者
相似试验
已完成
2 期
The efficacy of combination of Olanzapine, Aprepitant, Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving autologous peripheral blood stem cell transplantation for multiple myelomamultiple myelomaJPRN-UMIN000035970Hitachi general hospital52
已完成
3 期
Aprepitant and Olanzapine in the treatment of vomitingCTRI/2017/12/010869Mysore medical college ad research institute
招募中
3 期
Olanzapine versus Aprepitant in the triplet regimen for preventing highly emetogenic chemotherapy-induced nausea and vomiting: a double blind, non-inferiority, randomized phase 3 trialmalignant tumor(only solid tumor)JPRN-UMIN000034225Department of Surgery, Keio University School of Medicine130
招募中
3 期
Comparison between Olanzapine- Aprepitant- Granisetron on nausea and vomitingIRCT20190217042735N1Zahedan University of Medical Sciences105
尚未招募
不适用
To Compare the changes in Neurocognitive profile in patients suffering with schizophrenia on treatment with Aripiprazole and OlanzapineCTRI/2021/05/033511Government Medical College and Hospital